Scott Owen

1.5k total citations
41 papers, 439 citations indexed

About

Scott Owen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Scott Owen has authored 41 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 14 papers in Genetics. Recurrent topics in Scott Owen's work include Lung Cancer Treatments and Mutations (20 papers), Glioma Diagnosis and Treatment (14 papers) and Brain Metastases and Treatment (11 papers). Scott Owen is often cited by papers focused on Lung Cancer Treatments and Mutations (20 papers), Glioma Diagnosis and Treatment (14 papers) and Brain Metastases and Treatment (11 papers). Scott Owen collaborates with scholars based in Canada, United States and Germany. Scott Owen's co-authors include Luís Souhami, Kevin Petrecca, Valérie Panet-Raymond, Bassam Abdulkarim, George Shenouda, Marie‐Christine Guiot, Marie Christine Guiot, Fabiano Santos, Ayman Oweida and J. Rothenstein and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Scott Owen

38 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Owen Canada 12 248 199 145 65 57 41 439
Barbara O’Brien United States 14 170 0.7× 180 0.9× 239 1.6× 34 0.5× 108 1.9× 56 478
Maximilian J. Mair Austria 14 123 0.5× 211 1.1× 201 1.4× 95 1.5× 79 1.4× 45 539
Yukihiro Tsuchida Japan 8 202 0.8× 122 0.6× 102 0.7× 59 0.9× 74 1.3× 21 363
Lucy Gately Australia 9 100 0.4× 87 0.4× 130 0.9× 48 0.7× 47 0.8× 31 289
A. M. Stark Germany 8 132 0.5× 126 0.6× 147 1.0× 66 1.0× 72 1.3× 15 397
Ethan Srinivasan United States 9 108 0.4× 136 0.7× 93 0.6× 37 0.6× 81 1.4× 34 369
Anna F. Piotrowski United States 11 61 0.2× 176 0.9× 127 0.9× 33 0.5× 60 1.1× 26 374
Petr Burkoň Czechia 10 224 0.9× 87 0.4× 178 1.2× 50 0.8× 24 0.4× 35 348
Cosette D. Champion United States 8 107 0.4× 117 0.6× 91 0.6× 36 0.6× 29 0.5× 10 264
Shiao-Pei Weathers United States 12 105 0.4× 179 0.9× 237 1.6× 18 0.3× 65 1.1× 18 400

Countries citing papers authored by Scott Owen

Since Specialization
Citations

This map shows the geographic impact of Scott Owen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Owen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Owen more than expected).

Fields of papers citing papers by Scott Owen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Owen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Owen. The network helps show where Scott Owen may publish in the future.

Co-authorship network of co-authors of Scott Owen

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Owen. A scholar is included among the top collaborators of Scott Owen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Owen. Scott Owen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seitlinger, Joseph, Roni Rayes, Thupten Tsering, et al.. (2025). KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma. Clinical Lung Cancer. 26(6). e447–e455.e6. 1 indexed citations
2.
Groot, John Frederick De, Timothy F. Cloughesy, Donald A. Berry, et al.. (2024). Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma.. Journal of Clinical Oncology. 42(16_suppl). 2005–2005.
3.
4.
Chen, Yue, S. Macisaac, Matthew D. Young, et al.. (2024). Nunavimmi puvakkut kaggutimik aanniaqarniq: Qanuilirqitaa?Lung cancer in Nunavik: How are we doing? A retrospective matched cohort study. Canadian Medical Association Journal. 196(6). E177–E186. 3 indexed citations
5.
6.
Wong, Philip, Laura Masucci, Marie Florescu, et al.. (2023). Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases. Neuro-Oncology Advances. 5(1). vdad018–vdad018. 11 indexed citations
7.
Faye, Mame Daro, Jacob C. Easaw, Paula de Robles, et al.. (2023). Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma. Neuro-Oncology Advances. 5(1). vdad106–vdad106. 5 indexed citations
8.
Schmid, Severin, Enrico Maria Minnella, Roni Rayes, et al.. (2022). Neoadjuvant Prehabilitation Therapy for Locally Advanced Non–Small-Cell Lung Cancer: Optimizing Outcomes Throughout the Trajectory of Care. Clinical Lung Cancer. 23(7). 593–599. 12 indexed citations
9.
Sorin, Mark, Caroline Huynh, Roni Rayes, et al.. (2022). Neoadjuvant Targeted Therapy in Non–Small Cell Lung Cancer and Its Impact on Surgical Outcomes. Annals of Thoracic Surgery Short Reports. 1(1). 102–106. 1 indexed citations
10.
Owen, Scott, Jad Alshami, Marie‐Christine Guiot, et al.. (2022). Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib. OncoTargets and Therapy. Volume 15. 367–380. 2 indexed citations
11.
Owen, Scott, et al.. (2021). Metastatic Large-Cell Neuroendocrine Lung Carcinoma With ALK Fusion Oncogene With Partial Response to Alectinib. JCO Precision Oncology. 5(5). 802–807. 8 indexed citations
12.
Conter, Henry Jacob, Scott Owen, Anna Zhou, et al.. (2019). Cost-effectiveness of second-line atezolizumab in Canada for advanced non-small cell lung cancer (NSCLC). Journal of Medical Economics. 22(7). 625–637. 25 indexed citations
13.
Ali, Adnan, Sophie Camilleri‐Broët, V. Cohen, et al.. (2018). P2.01-04 Reducing Time to Molecular Diagnosis for Advanced NSCLC in the Context of a Reference Testing Center. Journal of Thoracic Oncology. 13(10). S666–S666. 1 indexed citations
14.
Juergens, Rosalyn A., Caroline Mariano, Jacques Jolivet, et al.. (2018). Real-World Benefit of Nivolumab in A Canadian Non-Small-Cell Lung Cancer Cohort. Current Oncology. 25(6). 384–392. 46 indexed citations
15.
Owen, Scott, et al.. (2018). Needle Thoracostomy: Does Changing Needle Length and Location Change Patient Outcome?. Prehospital and Disaster Medicine. 33(3). 237–244. 7 indexed citations
16.
Santos, Fabiano, George Shenouda, Kevin Petrecca, et al.. (2017). Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution. Journal of Neuro-Oncology. 132(3). 419–426. 61 indexed citations
17.
Shenouda, George, Luís Souhami, Kevin Petrecca, et al.. (2016). A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 97(3). 487–494. 35 indexed citations
18.
Santos, Fabiano, Luís Souhami, Valérie Panet-Raymond, et al.. (2015). Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution. Radiation Oncology. 10(1). 106–106. 14 indexed citations
19.
Owen, Scott & Luís Souhami. (2014). The Management of Brain Metastases in Non-Small Cell Lung Cancer. Frontiers in Oncology. 4. 248–248. 56 indexed citations
20.
Owen, Scott, et al.. (2008). Chemotherapy-Induced Small Bowel Perforation in a Patient with Extrapulmonary Small-Cell Carcinoma of the Small Bowel. Current Oncology. 15(6). 298–301. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara O’Brien Breakdown of academic impact, for papers by Maximilian J. Mair Breakdown of academic impact, for papers by Yukihiro Tsuchida Breakdown of academic impact, for papers by Lucy Gately Breakdown of academic impact, for papers by A. M. Stark Breakdown of academic impact, for papers by Ethan Srinivasan Breakdown of academic impact, for papers by Anna F. Piotrowski Breakdown of academic impact, for papers by Petr Burkoň Breakdown of academic impact, for papers by Cosette D. Champion Breakdown of academic impact, for papers by Shiao-Pei Weathers
Rankless by CCL
2026